Literature DB >> 1991802

Effects of glucagon on free fatty acid metabolism in humans.

M D Jensen1, V J Heiling, J M Miles.   

Abstract

To determine whether physiological changes in plasma glucagon concentrations are important in regulating basal adipose tissue lipolysis, FFA flux ([1-14C]palmitate) was measured in response to increases and decreases in plasma glucagon. Eight volunteers with insulin-dependent diabetes mellitus (IDDM) and nine healthy nondiabetic volunteers were studied using the pancreatic clamp technique to control plasma insulin, GH, and glucagon concentrations at desired levels. Palmitate flux at the chosen euglucagonemic hormone infusion rates was similar to baseline values (1.73 +/- 0.12 vs. 1.75 +/- 0.23 and 1.35 +/- 0.18 vs. 1.35 +/- 0.16 mumol/kg.min, respectively, in IDDM and nondiabetic subjects). No significant changes in palmitate flux occurred in response to glucagon withdrawal or mild (nondiabetic volunteers) or high physiological (IDDM volunteers) hyperglucagonemia. Thus, under conditions of normal FFA availability, changes in plasma glucagon concentrations within the physiological range have little or no effect on adipose tissue lipolysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991802     DOI: 10.1210/jcem-72-2-308

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Role of Glucagon in Automated Insulin Delivery.

Authors:  Leah M Wilson; Peter G Jacobs; Jessica R Castle
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12-10       Impact factor: 4.741

2.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition.

Authors:  Megan E Capozzi; Reilly W Coch; Jepchumba Koech; Inna I Astapova; Jacob B Wait; Sara E Encisco; Jonathan D Douros; Kimberly El; Brian Finan; Kyle W Sloop; Mark A Herman; David A D'Alessio; Jonathan E Campbell
Journal:  Diabetes       Date:  2020-01-31       Impact factor: 9.461

Review 4.  Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

5.  Glucagon responses in rabbits with obstructive jaundice and a low energy status in the liver.

Authors:  H Fujii; M Yamamoto; M Mogaki; K Miura; J Itakura; J Okuda; Y Matsumoto
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 6.  Multi-organ Coordination of Lipoprotein Secretion by Hormones, Nutrients and Neural Networks.

Authors:  Priska Stahel; Changting Xiao; Avital Nahmias; Lili Tian; Gary Franklin Lewis
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

7.  Glucagon Receptor Signaling and Lipid Metabolism.

Authors:  Katrine D Galsgaard; Jens Pedersen; Filip K Knop; Jens J Holst; Nicolai J Wewer Albrechtsen
Journal:  Front Physiol       Date:  2019-04-24       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.